{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T21:35:16Z","timestamp":1779312916291,"version":"3.51.4"},"reference-count":58,"publisher":"MDPI AG","issue":"4","license":[{"start":{"date-parts":[[2026,3,30]],"date-time":"2026-03-30T00:00:00Z","timestamp":1774828800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Microorganisms"],"abstract":"<jats:p>Sepsis is a life-threatening complication among patients with liver cirrhosis and is associated with high morbidity and mortality. Early diagnosis is challenging due to immune dysfunction, chronic systemic inflammation, and overlap between clinical and laboratory findings during infection and hepatic decompensation. Therefore, there is a need to identify routinely available predictors that may enable the stratifying of patients at risk of developing sepsis in this population and facilitate intensive monitoring, antibiotic treatment, and potentially reduce mortality. The aim of this study is to evaluate the association between routine laboratory parameters and the development of sepsis among cirrhotic patients. A total of 171 cirrhotic patients met the inclusion criteria and were followed at a tertiary liver clinic between February 2015 and February 2022. Sepsis was defined according to Sepsis-3 criteria. Univariate analyses were performed to compare sepsis patients versus non-sepsis patients. Multivariable logistic regression was conducted to identify independent predictors of sepsis. Among 171 patients, 41 (24%) developed sepsis and 130 (76%) did not. Baseline characteristics were similar between groups: patients with sepsis were slightly older (67.5 \u00b1 10.9 vs. 64.5 \u00b1 12.3 years, p = 0.172), with no significant differences in sex (53.7% vs. 56.2%, p = 0.78) or ethnicity (Arab ethnicity 56.1% vs. 39.1%, p = 0.055). Ascites was more frequent in the sepsis group (53.7% vs. 26.2%, p = 0.001), whereas esophageal varices were less common (12.2% vs. 35.4%, p = 0.006). Rates of hepatic encephalopathy and acute kidney injury did not differ significantly. Higher creatinine (1.35 (0.80\u20133.35) vs. 0.80 (0.70\u20131.49) mg\/dL, p &lt; 0.001), INR (1.50 (1.20\u20131.80) vs. 1.30 (1.10\u20131.50), p = 0.011), and total bilirubin (1.90 (0.61\u20132.85) vs. 0.90 (0.59\u20131.70) mg\/dL, p = 0.049) was observed in the sepsis group. In the multivariable model including age, sex, ethnicity, ascites, esophageal varices, INR, creatinine, neutrophil-to-lymphocyte ratio, and CRP, baseline serum creatinine was the only independent predictor of sepsis (adjusted OR 1.58 per 1 mg\/dL increase, 95% CI 1.08\u20132.33, p = 0.01). Receiver operating characteristic (ROC) analysis demonstrated that the multivariable model had acceptable discriminative ability for prediction of sepsis, with an area under the curve (AUC) of 0.741 (95% CI 0.647\u20130.835). Among ambulatory patients with liver cirrhosis, baseline serum creatinine was independently associated with the development of sepsis. These findings highlight the need for dedicated risk-stratification tools in the outpatient setting. Further external validation in independent cohorts is required.<\/jats:p>","DOI":"10.3390\/microorganisms14040785","type":"journal-article","created":{"date-parts":[[2026,3,30]],"date-time":"2026-03-30T13:41:53Z","timestamp":1774878113000},"page":"785","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Renal Impairment as an Independent Predictor of Sepsis in Cirrhosis: A Retrospective Cohort Study"],"prefix":"10.3390","volume":"14","author":[{"given":"Mariana","family":"Boulos","sequence":"first","affiliation":[{"name":"Internal Medicine Department, Galilee Medical Centre, Nahariya 2210001, Israel"},{"name":"Azrieli Bar-Ilan Faculty of Medicine, Bar-Ilan University, Safad 1311502, Israel"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lana","family":"Majdoub","sequence":"additional","affiliation":[{"name":"Internal Medicine Department, Galilee Medical Centre, Nahariya 2210001, Israel"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maamoun","family":"Basheer","sequence":"additional","affiliation":[{"name":"Internal Medicine Department, Galilee Medical Centre, Nahariya 2210001, Israel"},{"name":"Azrieli Bar-Ilan Faculty of Medicine, Bar-Ilan University, Safad 1311502, Israel"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2279-6041","authenticated-orcid":false,"given":"Nimer","family":"Assy","sequence":"additional","affiliation":[{"name":"Internal Medicine Department, Galilee Medical Centre, Nahariya 2210001, Israel"},{"name":"Azrieli Bar-Ilan Faculty of Medicine, Bar-Ilan University, Safad 1311502, Israel"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2026,3,30]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"2317","DOI":"10.1056\/NEJMra2021808","article-title":"The Evolving Challenge of Infections in Cirrhosis","volume":"384","author":"Bajaj","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1038\/s41575-021-00520-7","article-title":"Cirrhosis-associated immune dysfunction","volume":"19","author":"Albillos","year":"2022","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1093\/intimm\/dxac030","article-title":"Liver cirrhosis and immune dysfunction","volume":"34","author":"Hasa","year":"2022","journal-title":"Int. Immunol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"2133","DOI":"10.1056\/NEJMra2403213","article-title":"Sepsis and Septic Shock","volume":"391","author":"Meyer","year":"2024","journal-title":"N. Engl. J. Med."},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Maslennikov, R., Poluektova, E., Zolnikova, O., Sedova, A., Kurbatova, A., Shulpekova, Y., Dzhakhaya, N., Kardasheva, S., Nadinskaia, M., and Bueverova, E. (2023). Gut Microbiota and Bacterial Translocation in the Pathogenesis of Liver Fibrosis. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms242216502"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/S2468-1253(24)00078-5","article-title":"Infections in cirrhosis","volume":"9","author":"Piano","year":"2024","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"e11421","DOI":"10.1097\/MD.0000000000011421","article-title":"Comparison of the predictive value of scoring systems on the prognosis of cirrhotic patients with suspected infection","volume":"97","author":"Lan","year":"2018","journal-title":"Medicine"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1892","DOI":"10.1136\/gutjnl-2017-314324","article-title":"Assessment of Sepsis-3 criteria and quick SOFA in patients with cirrhosis and bacterial infections","volume":"67","author":"Piano","year":"2018","journal-title":"Gut"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1186\/s13054-025-05423-6","article-title":"Identifying a unique signature of sepsis in patients with pre-existing cirrhosis","volume":"29","author":"Dasgupta","year":"2025","journal-title":"Crit. Care"},{"key":"ref_10","first-page":"603","article-title":"Acute phase proteins in the diagnosis and prediction of cirrhosis associated bacterial infections","volume":"32","author":"Papp","year":"2012","journal-title":"Liver Int. Off. J. Int. Assoc. Study Liver."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1097\/MEG.0000000000001081","article-title":"Clarifying the role of C-reactive protein as a bacterial infection predictor in decompensated cirrhosis","volume":"30","author":"Perdigoto","year":"2018","journal-title":"Eur. J. Gastroenterol. Hepatol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1136\/gutjnl-2023-329923","article-title":"Novel prognostic biomarkers in decompensated cirrhosis: A systematic review and meta-analysis","volume":"73","author":"Juanola","year":"2023","journal-title":"Gut"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"20039","DOI":"10.1038\/s41598-023-47384-2","article-title":"Markers of inflammation predict survival in newly diagnosed cirrhosis: A prospective registry study","volume":"13","author":"Webel","year":"2023","journal-title":"Sci. Rep."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1016\/j.jcrc.2015.03.031","article-title":"Interleukin-6 as an early diagnostic marker for bacterial sepsis in patients with liver cirrhosis","volume":"30","author":"Lin","year":"2015","journal-title":"J. Crit. Care"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"99506","DOI":"10.3748\/wjg.v31.i6.99506","article-title":"Procalcitonin and presepsin for detecting bacterial infection and spontaneous bacterial peritonitis in cirrhosis: A systematic review and meta-analysis","volume":"31","author":"Wejnaruemarn","year":"2025","journal-title":"World J. Gastroenterol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"119891","DOI":"10.1016\/j.cca.2024.119891","article-title":"Biomarkers in sepsis","volume":"562","author":"Saxena","year":"2024","journal-title":"Clin. Chim. Acta Int. J. Clin. Chem."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"43266","DOI":"10.1038\/s41598-025-30647-5","article-title":"IL-1 receptor antagonist as a diagnostic biomarker for bacterial infections in acute decompensation of cirrhosis","volume":"15","author":"Konstantis","year":"2025","journal-title":"Sci. Rep."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"14033","DOI":"10.1038\/s41598-021-93635-5","article-title":"Relative platelet reductions provide better pathophysiologic signatures of coagulopathies in sepsis","volume":"11","author":"Kasugai","year":"2021","journal-title":"Sci. Rep."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"120558","DOI":"10.1016\/j.cca.2025.120558","article-title":"Diagnostic utility of combined coagulation and inflammatory biomarkers in sepsis stratification: A retrospective study","volume":"578","author":"Ding","year":"2026","journal-title":"Clin. Chim. Acta Int. J. Clin. Chem."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1056\/NEJMra2403308","article-title":"Noninvasive Assessment of Liver Fibrosis","volume":"393","author":"Castera","year":"2025","journal-title":"N. Engl. J. Med."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1016\/S0140-6736(21)01374-X","article-title":"Liver cirrhosis","volume":"398","author":"Krag","year":"2021","journal-title":"Lancet"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1001\/jama.2023.5997","article-title":"Diagnosis and Management of Cirrhosis and Its Complications: A Review","volume":"329","author":"Tapper","year":"2023","journal-title":"JAMA"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1053\/j.gastro.2021.08.050","article-title":"MELD 3.0: The Model for End-Stage Liver Disease Updated for the Modern Era","volume":"161","author":"Kim","year":"2021","journal-title":"Gastroenterology"},{"key":"ref_24","unstructured":"(2026, January 30). The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3)|Critical Care Medicine|JAMA|JAMA Network. Available online: https:\/\/jamanetwork.com\/journals\/jama\/fullarticle\/2492881?utm_source=openevidence&utm_medium=referral."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1007\/s12072-014-9580-2","article-title":"Acute-on-chronic liver failure: Consensus recommendations of the Asian Pacific Association for the Study of the Liver (APASL) 2014","volume":"8","author":"Sarin","year":"2014","journal-title":"Hepatol. Int."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1016\/j.jhep.2014.08.010","article-title":"Cirrhosis-associated immune dysfunction: Distinctive features and clinical relevance","volume":"61","author":"Albillos","year":"2014","journal-title":"J. Hepatol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/j.jhep.2020.07.046","article-title":"Clinical features and evolution of bacterial infection-related acute-on-chronic liver failure","volume":"74","author":"Wong","year":"2021","journal-title":"J. Hepatol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1378\/chest.124.3.1016","article-title":"Cirrhosis as a risk factor for sepsis and death: Analysis of the National Hospital Discharge Survey","volume":"124","author":"Foreman","year":"2003","journal-title":"Chest"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1111\/ajt.16142","article-title":"Validation of the Model for End-stage Liver Disease sodium (MELD-Na) score in the Eurotransplant region","volume":"21","author":"Goudsmit","year":"2021","journal-title":"Am. J. Transplant. Off. J. Am. Soc. Transplant. Am. Soc. Transpl. Surg."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1016\/j.jhep.2014.11.012","article-title":"The CLIF Consortium Acute Decompensation score (CLIF-C ADs) for prognosis of hospitalised cirrhotic patients without acute-on-chronic liver failure","volume":"62","author":"Jalan","year":"2015","journal-title":"J. Hepatol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1053\/jhep.2003.50038","article-title":"Increased lipopolysaccharide binding protein in cirrhotic patients with marked immune and hemodynamic derangement","volume":"37","author":"Albillos","year":"2003","journal-title":"Hepatology"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1007\/s11739-023-03374-w","article-title":"Gut microbiota, intestinal permeability, and systemic inflammation: A narrative review","volume":"19","author":"Petito","year":"2024","journal-title":"Intern. Emerg. Med."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1056\/NEJMra2215289","article-title":"Acute Kidney Injury in Patients with Cirrhosis","volume":"388","author":"Nadim","year":"2023","journal-title":"N. Engl. J. Med."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1097\/HEP.0000000000000647","article-title":"AASLD Practice Guidance on risk stratification and management of portal hypertension and varices in cirrhosis","volume":"79","author":"Kaplan","year":"2024","journal-title":"Hepatology"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1002\/hep.28264","article-title":"Development of hyperdynamic circulation and response to \u03b2-blockers in compensated cirrhosis with portal hypertension","volume":"63","author":"Villanueva","year":"2016","journal-title":"Hepatology"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"7321","DOI":"10.3748\/wjg.v23.i40.7321","article-title":"Medication beliefs predict medication adherence in ambulatory patients with decompensated cirrhosis","volume":"23","author":"Hayward","year":"2017","journal-title":"World J. Gastroenterol."},{"key":"ref_37","first-page":"1882","article-title":"Optimizing medication management for patients with cirrhosis: Evidence-based strategies and their outcomes","volume":"38","author":"Thomson","year":"2018","journal-title":"Liver Int. Off. J. Int. Assoc. Study Liver."},{"key":"ref_38","doi-asserted-by":"crossref","unstructured":"Sauerbruch, T., Hennenberg, M., Trebicka, J., and Schierwagen, R. (2022). Beta-blockers in patients with liver cirrhosis: Pragmatism or perfection?. Front. Med., 9.","DOI":"10.3389\/fmed.2022.1100966"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"1758","DOI":"10.1136\/gutjnl-2020-322712","article-title":"Amelioration of systemic inflammation in advanced chronic liver disease upon beta-blocker therapy translates into improved clinical outcomes","volume":"70","author":"Jachs","year":"2021","journal-title":"Gut"},{"key":"ref_40","doi-asserted-by":"crossref","unstructured":"Song, F., Wu, X.L., and Wei, B.H. (2025). Prognostic value of neutrophil-to-lymphocyte ratio in septic patients with liver cirrhosis: A cohort study. BMC Gastroenterol., 25.","DOI":"10.1186\/s12876-025-04157-7"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1097\/MEG.0b013e32835c2af3","article-title":"Blood neutrophil-to-lymphocyte ratio independently predicts survival in patients with liver cirrhosis","volume":"25","author":"Biyik","year":"2013","journal-title":"Eur. J. Gastroenterol. Hepatol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1080\/00325481.2021.1916258","article-title":"Neutrophil-to-lymphocyte ratio: An accurate method for diagnosing infection in cirrhosis","volume":"133","author":"Rosa","year":"2021","journal-title":"Postgrad. Med."},{"key":"ref_43","doi-asserted-by":"crossref","unstructured":"Lin, J., Huang, M., and Shen, L. (2025). Predictive value of neutrophil to lymphocyte ratio for clinical outcomes in liver cirrhosis: A systematic review and meta-analysis. PLoS ONE, 20.","DOI":"10.1371\/journal.pone.0335925"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/s13054-014-0731-6","article-title":"The association between the neutrophil-to-lymphocyte ratio and mortality in critical illness: An observational cohort study","volume":"19","author":"Salciccioli","year":"2015","journal-title":"Crit. Care"},{"key":"ref_45","doi-asserted-by":"crossref","unstructured":"Buonacera, A., Stancanelli, B., Colaci, M., and Malatino, L. (2022). Neutrophil to Lymphocyte Ratio: An Emerging Marker of the Relationships between the Immune System and Diseases. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms23073636"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1038\/s41423-025-01354-y","article-title":"Molecular mechanisms and regulation of inflammasome activation and signaling: Sensing of pathogens and damage molecular patterns","volume":"22","author":"Dubey","year":"2025","journal-title":"Cell. Mol. Immunol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"112789","DOI":"10.1016\/j.biopha.2022.112789","article-title":"The contribution of sterile inflammation to the fatty liver disease and the potential therapies","volume":"148","author":"Shaker","year":"2022","journal-title":"Biomed. Pharmacother."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1038\/s41392-024-02049-y","article-title":"Neutrophil diversity and function in health and disease","volume":"9","author":"Zhang","year":"2024","journal-title":"Signal Transduct. Target. Ther."},{"key":"ref_49","doi-asserted-by":"crossref","unstructured":"Gao, Z., Feng, Y., Xu, J., and Liang, J. (2022). T-cell exhaustion in immune-mediated inflammatory diseases: New implications for immunotherapy. Front. Immunol., 13.","DOI":"10.3389\/fimmu.2022.977394"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1007\/s12072-023-10577-y","article-title":"Von Willebrand factor processing in patients with advanced chronic liver disease and its relation to portal hypertension and clinical outcome","volume":"17","author":"Simbrunner","year":"2023","journal-title":"Hepatol. Int."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1002\/hep.30230","article-title":"Serum Angiopoietin-2 Predicts Mortality and Kidney Outcomes in Decompensated Cirrhosis","volume":"69","author":"Allegretti","year":"2019","journal-title":"Hepatology"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1111\/hepr.12886","article-title":"Clinical characteristics and prognostic factors of liver cirrhosis patients with systemic inflammatory response syndrome","volume":"47","author":"Yang","year":"2017","journal-title":"Hepatol. Res. Off. J. Jpn. Soc. Hepatol."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.jhep.2009.04.017","article-title":"The systemic inflammatory response syndrome in cirrhotic patients: Relationship with their in-hospital outcome","volume":"51","author":"Cazzaniga","year":"2009","journal-title":"J. Hepatol."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1136\/gut.2008.154120","article-title":"The systemic inflammatory response syndrome is predictive of renal dysfunction in patients with non-paracetamol-induced acute liver failure","volume":"58","author":"Leithead","year":"2009","journal-title":"Gut"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1681\/ASN.2007070744","article-title":"IL-6\/IL-6R axis plays a critical role in acute kidney injury","volume":"19","author":"Barkan","year":"2008","journal-title":"J. Am. Soc. Nephrol. JASN"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.jhep.2023.04.021","article-title":"EASL Clinical Practice Guidelines on acute-on-chronic liver failure","volume":"79","author":"Moreau","year":"2023","journal-title":"J. Hepatol."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.jhep.2024.03.030","article-title":"Developing and validating clinical prediction models in hepatology\u2014An overview for clinicians","volume":"81","author":"Strandberg","year":"2024","journal-title":"J. Hepatol."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1136\/gutjnl-2024-333876","article-title":"Gene score to quantify systemic inflammation in patients with acutely decompensated cirrhosis","volume":"74","author":"Trebicka","year":"2025","journal-title":"Gut"}],"container-title":["Microorganisms"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2076-2607\/14\/4\/785\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,30]],"date-time":"2026-03-30T13:53:30Z","timestamp":1774878810000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2076-2607\/14\/4\/785"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,30]]},"references-count":58,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2026,4]]}},"alternative-id":["microorganisms14040785"],"URL":"https:\/\/doi.org\/10.3390\/microorganisms14040785","relation":{},"ISSN":["2076-2607"],"issn-type":[{"value":"2076-2607","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,30]]}}}